These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-002979-16 A Six-Week/Six-Week, Prospective, Randomised, Masked, Cross over, Primary Therapy Study comparing IOP Lowering Effects of Lumigan® and Xalatan® in Subjects with Primary Open Angle Glaucoma, Ocular Hy... 2006-08-08 due-trials
Ongoing 2005-000115-10 A randomised, double blind, placebo-controlled, cross-over study of the effects of dehydroepiandrosterone replacement on vascular function in patients with primary and secondary adrenal insufficiency. not-yet-due
Ongoing 2005-000749-13 A Randomised Double-Blind Trial of Medical Treatment In Marfan Syndrome. not-yet-due
Ongoing 2005-000817-37 A Study On The Efficacy Of Delta-9-Tetrahydrocannabinol (Dronabinol) In Renal Itch not-yet-due
Ongoing 2005-001291-12 Histamine Release and Implications of H1- and H2- Blockade in Adult Cardiac Surgery - A Randomised Controlled Study not-yet-due
Exempt 2005-001588-78 AML16 Pilot Trial: A Phase1/2 Trial to assess the feasibility of combining Clofarabine with daunorubicin and Daunorubicin + Clofarabine with Mylotarg in older patients with Acute Myeloid Leukaemia and... not-yet-due
Ongoing 2005-002847-14 AML16; A National Cancer Research Institute Trial in Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndromes not-yet-due
Ongoing 2005-003681-42 The effects of Acacia (sen) SUPERGUM (Gum Arabic) on renal physiology and arterial function in type II diabetic patients not-yet-due
Ongoing 2005-004754-27 Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes not-yet-due
Ongoing, reported early 2005-005470-69 A randomised, double-blind, placebo-controlled crossover trial of the effects of metformin therapy on vascular and metabolic risk in young women with polycystic ovary syndrome. not-yet-due
Reported results 2006-004327-11 A randomised phase II multi-centre trial of topical treatment in women with vulval intraepithelial neoplasia 2014-01-24 due-trials
Ongoing 2007-000056-14 Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test not-yet-due
Ongoing 2007-003798-16 AML 17: A Programme of Treatment Development in Younger Patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome not-yet-due
Ongoing 2007-005647-14 Gamma Delta T Cells and their role in the acute phase reaction to intravenous bisphosphonates not-yet-due
Ongoing 2007-006227-12 A randomised, placebo controlled study of nebulised magnesium in acute severe asthma in children not-yet-due
Ongoing, reported early 2007-007591-42 A Phase II single-arm trial to evaluate cisplatin and gemcitabine chemotherapy in combination with sunitinib for first-line treatment of patients with advancd transitional carcinoma of the urothelium. not-yet-due
Ongoing, reported early 2007-007615-82 A Phase I/II single-arm trial to evaluate the combination of cisplatin and gemcitabine with the mTOR inhibitor temsirolimus for treatment of advanced cancers, including first-line treatment of patient... not-yet-due
Not reported 2008-000475-25 Randomised, controlled, double-blind, parallel group clinical trial evaluating the efficacies and safety of methyl-aminolevulinate photodynamic therapy and intense pulsed light, administered as place... 2012-08-13 due-trials
Ongoing, reported early 2008-001394-15 A multi-centre randomised phase II study of induction chemotherapy followed by gemcitabine or capecitabine based chemoradiotherapy (CRT) for locally advanced non-metastatic pancreatic cancer not-yet-due
Ongoing, reported early 2009-010140-33 A randomised phase II Trial of carboplatin and gemcitabine +/- vandetanib in first line treatment Of advanced Urothelial cell Cancer in patients who are not suitable to receive cisplatin not-yet-due
Ongoing 2009-012151-23 A randomised phase II study of Irinotecan, 5-Fluorouracil and Folinic Acid (FOLFIRI) with or without the addition of an endothelin receptor antagonist in patients with metastatic colorectal cancer aft... not-yet-due
Not reported Terminated 2010-018837-23 A randomised Phase II study of carboplatin with or without the addition of the ETAR inhibitor ZD4054 as treatment for patients with metastatic breast cancer. 2011-08-09 due-trials
Ongoing 2010-021444-18 TO ESTABLISH THE FEASIBILITY OF COMBINING EITHER THE TYROSINE KINASE INHIBITOR AC220 OR THE CXCR4 INHIBITOR PLERIXAFOR OR THE HSP90 INHIBITOR, GANETESPIB, WITH CHEMOTHERAPY IN OLDER PATIENTS WITH ACUT... not-yet-due
Reported results Terminated 2010-023083-40 A Phase II study of neoadjuvant chemotherapy given before SCPRT as treatment for patients with MRI-staged operable rectal cancer at high risk of metastatic relapse 2015-04-14 due-trials
Ongoing, reported early 2010-023476-23 Seal or Varnish? A Randomised Trial To Determine The Relative Cost And Effectiveness Of Pit And Fissure Sealants And Fluoride Varnish In Preventing Dental Decay not-yet-due
Not reported 2010-024380-41 A pilot study to assess the effect of regulatory T-cell depletion on 5T4-containing MVA(TroVax®)vaccination in patients with inoperable metastatic colorectal cancer 2016-06-23 due-trials
Ongoing 2011-000749-19 Bloodwise and NCRI Working Group Pick a Winner Programme (LI-1) Trial not-yet-due
No trial status on register, and reported results 2011-003591-37 Children with Eczema Antibiotic Management Study (CREAM) bad-data
Completed, report not yet due 2011-004854-25 TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis. 2018-08-06 not-yet-due
Ongoing 2011-006269-17 A double blind placebo controlled randomised clinical trial to study the effect of Probiotics for the prevetion or amelioration of Antibiotic Associated Diarrhoea in residents of care homes in South W... not-yet-due
Ongoing 2012-004117-14 A feasibility study to inform the design of a randomised controlled trial to identify the most clinically and cost effective length of Anticoagulation with Low molecular weight heparin In the treatmen... not-yet-due
Ongoing, reported early 2012-005123-32 Oral steroids for the resolution of otitis media with effusion in children study (OSTRICH) not-yet-due
Reported results 2012-005511-11 Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a prospective double blind randomised control trial 2015-11-26 due-trials
Reported results 2013-000389-12 ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial 2016-06-30 due-trials
Not reported Terminated 2013-000501-22 A national cancer research institute acute myeloid leukaemia working group pilot trial under the auspices of the cardiff experimental cancer medicine centre to establish the feasibility of combining t... 2015-06-03 due-trials
Other 2013-002730-21 A Trial for Older Patients with Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome not-yet-due
Not reported 2014-000540-15 Prostaglandin F2-alpha eye drops (Bimatoprost) in thyroid eye disease: a randomised controlled double blind crossover trial 2016-04-15 due-trials
Ongoing 2014-002195-90 Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (AML19) not-yet-due
Ongoing 2014-005088-34 A randomised controlled, double blind trial investigating the efficacy of fluoxetine treatment in improving memory and learning impairments in patients with mesial temporal lobe epilepsy: Fluoxetine, ... not-yet-due
Ongoing 2015-002281-23 A phase 2 study of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukaemia (CMML) not-yet-due
Exempt 2015-003934-28 Enhanced Epidermal Antigen Specific Immunotherapy trial -1 (EE-ASI-1): A Phase 1a study of gold nanoparticles administered intradermally by microneedles to deliver immunotherapy with a proinsulin deri... not-yet-due